ISANESTHESIA
ActiveSummary
ISANESTHESIA has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €209,579 and a net result of €57,445. Equity is growing by ~30.9% per year across the filed fiscal years. Its solvency ranks better than 71% of 19918 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability97=
Solvency100▲+10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19,000 at 30 days acceptable
Liquidity ample (current ratio 7.53 against 3.23 in 2023; short-term debt: 11% and cash: 17.6% of total assets), and 17.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
1 d early
2023
29 d late
2022
39 d early
2021
2 d early
2020
30 d late
2019
3 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 2 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€209,579▲ 28.1%
2023 · €163,635
Total assets
€253,279▲ 1.1%
2023 · €250,579
Net result
€57,445▲ 1.4%
2023 · €56,665
Working capital
€182,538▲ 33.9%
2023 · €136,325
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€9,025▼ 53.8%€26,193▲ 190%€90,903▲ 247%€81,142▼ 10.7%€83,211▲ 2.5%
Net result€3,703below the sector's middle half▼ 67.8%€15,892below the sector's middle half▲ 329%€61,613within the sector's middle half▲ 288%€56,665within the sector's middle half▼ 8.0%€57,445within the sector's middle half▲ 1.4%
Equity€57,787within the sector's middle half▲ 6.8%€73,680within the sector's middle half▲ 27.5%€122,576within the sector's middle half▲ 66.4%€163,635within the sector's middle half▲ 33.5%€209,579within the sector's middle half▲ 28.1%
Total assets€80,262below the sector's middle half▼ 7.1%€91,291below the sector's middle half▲ 13.7%€168,684within the sector's middle half▲ 84.8%€250,579within the sector's middle half▲ 48.5%€253,279within the sector's middle half▲ 1.1%
Debt€22,475▼ 30.4%€17,611▼ 21.6%€46,107▲ 162%€86,943▲ 88.6%€43,700▼ 49.7%
Working capital€44,655▲ 19.2%€61,695▲ 38.2%€116,829▲ 89.4%€136,325▲ 16.7%€182,538▲ 33.9%
Solvency72.0%within the sector's middle half▲ 9.4pp80.7%within the sector's middle half▲ 8.7pp72.7%within the sector's middle half▼ 8.0pp65.3%within the sector's middle half▼ 7.4pp82.7%within the sector's middle half▲ 17.4pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 3% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €253,279
Fixed assets
€42,788 ▼ 19.3%
Current assets
€210,491 ▲ 6.6%
Equity and liabilities €253,279
Equity
€209,579 ▲ 28.1%
Debt
€43,700 ▼ 49.7%
Debt's share of the balance-sheet total falls from 34.7% to 17.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€96,123▲
2023 · €88,462
Cash flow
€70,357▲
2023 · €63,985
Current ratio
7.53▲
2023 · 3.23
Debt to equity
0.21▼
2023 · 0.53
ROE
27.4%▼
2023 · 34.6%
ROA
22.7%▲
2023 · 22.6%
Interest coverage
50.15▼
2023 · 63.20
Debt ≤ 1 year
€27,953▼
2023 · €61,205
Debt > 1 year
€15,748▼
2023 · €25,738
Income taxes
€23,850▲
2023 · €23,077
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,672 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
3.9%
stopped otherwise
95%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,672 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €11,700 | €12,077 | €12,369 | €7,319 | €12,912 | ▲ 76.4% |
| Other operating charges640/8 | - | €348 | €482 | €384 | €514 | ▲ 33.6% |
| Gross operating margin9900 | €21,155 | €38,618 | €103,753 | €88,846 | €96,637 | ▲ 8.8% |
| Operating profit (loss)9901 | €9,025 | €26,193 | €90,903 | €81,142 | €83,211 | ▲ 2.5% |
| Recurring financial income75 | €0 | - | - | - | - | - |
| Financial charges65/66B | - | €468 | €388 | €1,400 | €1,917 | ▲ 36.9% |
| Recurring financial charges65 | €574 | €468 | €388 | €1,400 | €1,917 | ▲ 36.9% |
| Profit (loss) for the period before taxes9903 | €8,451 | €25,726 | €90,515 | €79,743 | €81,294 | ▲ 1.9% |
| Income taxes67/77 | €4,748 | €9,833 | €28,902 | €23,077 | €23,850 | ▲ 3.3% |
| Profit (loss) for the period9904 | €3,703 | €15,892 | €61,613 | €56,665 | €57,445 | ▲ 1.4% |
| Profit (loss) for the period to be appropriated9905 | €3,703 | €15,892 | €61,613 | €56,665 | €57,445 | ▲ 1.4% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €80,262 | €91,291 | €168,684 | €250,579 | €253,279 | ▲ 1.1% |
| Fixed assets21/28 | €25,805 | €16,689 | €5,748 | €53,048 | €42,788 | ▼ 19.3% |
| Tangible fixed assets22/27 | €25,805 | €16,689 | €5,748 | €53,048 | €42,788 | ▼ 19.3% |
| Land and buildings22 | - | €1,425 | €1,068 | €712 | €356 | ▼ 50.0% |
| Plant, machinery and equipment23 | - | €1,724 | €1,478 | €1,231 | €985 | ▼ 20.0% |
| Furniture and vehicles24 | - | €13,540 | €3,202 | €51,104 | €41,447 | ▼ 18.9% |
| Current assets29/58 | €54,457 | €74,602 | €162,936 | €197,531 | €210,491 | ▲ 6.6% |
| Amounts receivable within one year40/41 | €31,232 | €32,491 | €61,391 | €86,360 | €101,420 | ▲ 17.4% |
| Trade receivables40 | - | - | €2,000 | €4,000 | - | - |
| Other amounts receivable41 | - | €32,491 | €59,391 | €82,360 | €101,420 | ▲ 23.1% |
| Cash at bank and in hand54/58 | €6,111 | €16,961 | €48,720 | €55,965 | €44,606 | ▼ 20.3% |
| Deferred charges and accrued income490/1 | - | €25,150 | €52,825 | €55,206 | €64,465 | ▲ 16.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €80,262 | €91,291 | €168,684 | €250,579 | €253,279 | ▲ 1.1% |
| Equity10/15 | €57,787 | €73,680 | €122,576 | €163,635 | €209,579 | ▲ 28.1% |
| Contributions10/11 | - | €12,400 | €12,400 | €14,260 | €14,260 | = |
| Reserves13 | €45,387 | €61,280 | €110,176 | €149,375 | €195,319 | ▲ 30.8% |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | - | - | - |
| Distributable reserves133 | - | €59,420 | €108,316 | €149,375 | €195,319 | ▲ 30.8% |
| Amounts payable17/49 | €22,475 | €17,611 | €46,107 | €86,943 | €43,700 | ▼ 49.7% |
| Amounts payable after more than one year17 | €12,672 | €4,704 | - | €25,738 | €15,748 | ▼ 38.8% |
| Financial debts170/4 | - | €4,704 | - | €25,738 | €15,748 | ▼ 38.8% |
| Amounts payable within one year42/48 | €9,803 | €12,907 | €46,107 | €61,205 | €27,953 | ▼ 54.3% |
| Current portion of amounts payable after more than one year42 | - | €7,968 | €4,704 | €9,602 | €9,990 | ▲ 4.0% |
| Trade debts44 | €24 | €675 | €5,521 | €2,087 | €680 | ▼ 67.4% |
| Suppliers440/4 | - | €675 | €5,521 | €2,087 | €680 | ▼ 67.4% |
| Taxes, remuneration and social security45 | - | €4,264 | €23,802 | €34,690 | €6,356 | ▼ 81.7% |
| Taxes450/3 | - | €4,264 | €23,802 | €34,690 | €6,356 | ▼ 81.7% |
| Other amounts payable47/48 | - | - | €12,081 | €14,826 | €10,926 | ▼ 26.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €3,703 | €15,892 | €61,613 | €56,665 | €57,445 | ▲ 1.4% |
| + Depreciation and write-downs630 | €11,700 | €12,077 | €12,369 | €7,319 | €12,912 | ▲ 76.4% |
| Operating cash flow (approximation) | €15,403 | €27,969 | €73,982 | €63,985 | €70,357 | ▲ 10.0% |
| Investment in fixed assets (approximation) | - | -€2,961 | -€1,428 | -€54,619 | -€2,652 | ▲ 95.1% |
| Change in cash | - | €10,850 | €31,759 | €7,245 | -€11,359 | ▼ 257% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity doublescurrent ratio 7.53
Current ratio from 3.23 to 7.53; short-term debt falls from €61,205 to €27,953.
31-12
Financial
Equity above €200,000Eq €209,579 ▲28.1%
7 profitable years in a row build equity to €209,579.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial
Equity above €150,000Eq €163,635 ▲33.5%
6 profitable years in a row build equity to €163,635.
22-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2018net €61,613 ▲288%
Operating result €90,903, net result €61,613, both a record.
31-12
Financial
Equity above €100,000Eq €122,576 ▲66.4%
5 profitable years in a row build equity to €122,576.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-12
Financial
Weakest financial yearnet €3,703 ▼67.8%
Net result drops to €3,703, the lowest in the series; recovery starts the following year.
28-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
31-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
20-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
28-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Villers-la-Ville · 2 establishment units since 2008
Ground area
2,398 m²
Building footprint
215 m²
Volume, LiDAR
471 m³
2 parcels, Wallonia · tallest building 6.2 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
2 establishment units
Rue du Drabe 34, 1440 Braine-le-Château
since 20082.186.564.003
Rue du Calvaire 11, 1495 Villers-la-Ville
since 20082.186.564.397
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25062H0389/00L000 | Wallonia | 1,419 m² | 1 · 121 m² | - |
| 25015A0435/00A000 | Wallonia | 979 m² | 1 · 94 m² | 6.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CDT Anesthesie
BE 0797.819.753
Grimbergen · Eq €209,546
OPHTASENS
BE 0777.945.245
Sint-Gillis (bij-Brussel) · Eq €209,648
CHIREST
BE 1013.395.820
Chaudfontaine · Eq €209,490
CINO
BE 0791.538.806
Kortrijk · Eq €209,486
Dokter R. CLAEYS, klinische biologie
BE 0882.782.944
Scherpenheuvel-Zichem · Eq €209,771
Of 16,631 companies in sector 86220 we hold annual accounts for 7,983. 6,662 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-04-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0897213277
Also
9925:BE0897213277
Registered
23-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.